Combination therapy
- 专利权人:
- Boehringer Ingelheim International GmbH
- 发明人:
- Thomas Klein,Rolf Grempler,Michael Mark
- 申请号：
- US15428594
- 公开号：
- US10004747B2
- 申请日:
- 2017.02.09
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要：
- The present invention relates to methods for treating and/or preventing metabolic diseases comprising the combined administration of a GLP-1 receptor agonist and a DPP-4 inhibitor.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Combination therapy comprising SGLT inhibitors and DPP4 inhibitors
- COMBINATION THERAPY COMPRISING SGLT INHIBITORS AND DPP4 INHIBITORS
- Combination therapy comprising sglt inhibitors and dpp4 inhibitors
- Combination therapy consisting of SGLT inhibitor and DPP4 inhibitor
- Combination therapy consisting of SGLT inhibitor and DPP4 inhibitor
